Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)

China · Delayed Price · Currency is CNY

30.79

-0.34 (-1.09%)

At close: Sep 11, 2026

SHA:603014 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,762	3,769	3,604	3,532	3,426	2,911
Revenue Growth	0.53%	4.57%	2.04%	3.09%	17.71%	-
Gross Profit	1,446	1,510	1,516	1,542	1,467	1,358
Operating Income	539.95	542.65	514.85	477.11	320.93	350.7
Net Income	491.82	482.3	449.37	442.07	314.96	259.82
Earnings Per Share	1.19	1.22	1.21	1.19	0.87	0.74
EPS Growth	-4.95%	0.83%	1.68%	37.47%	16.98%	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	3,439	3,401	3,402	3,361	-
Other Countries and Regions	329.26	202.96	129.94	64.97	48.73
Total	3,769	3,604	3,532	3,426	2,778

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,672	2,805	1,148	719.73	595.98	332.66
Total Debt	20.84	2.93	11.3	10.55	45.6	800.68
Net Cash (Debt)	2,651	2,802	1,137	709.18	550.38	-468.02
Net Cash Growth	16.48%	146.47%	60.32%	28.85%	-	-
Net Cash Per Share	6.40	7.09	3.06	1.92	1.51	-1.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	733.56	793.71	572.3	288.14	727.33	504.89
Capital Expenditures	-173.12	-159.85	-179.3	-232.81	-279.8	-401.25
Free Cash Flow	560.45	633.86	393	55.33	447.53	103.64
Free Cash Flow Growth	6.60%	61.29%	610.28%	-87.64%	331.80%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.44%	40.08%	42.06%	43.67%	42.83%	46.65%
Operating Margin	14.35%	14.40%	14.29%	13.51%	9.37%	12.05%
Pretax Margin	15.30%	15.28%	15.14%	14.83%	10.68%	10.97%
Profit Margin	13.07%	12.80%	12.47%	12.52%	9.19%	8.93%
FCF Margin	14.90%	16.82%	10.90%	1.57%	13.06%	3.56%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	0.518	0.518
Dividend Per Share Growth	0%	-
Dividend Yield	1.68%	1.32%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	25.94	34.33	-	-	-	-
Forward PE	25.80	31.27	-	-	-	-
P/FCF Ratio	22.95	26.12	-	-	-	-
PS Ratio	3.42	4.39	-	-	-	-